0000950170-24-141456.txt : 20241231 0000950170-24-141456.hdr.sgml : 20241231 20241231133238 ACCESSION NUMBER: 0000950170-24-141456 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20241231 DATE AS OF CHANGE: 20241231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fabbio Patrick CENTRAL INDEX KEY: 0001658859 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 241592258 MAIL ADDRESS: STREET 1: 2 PITNEY COURT CITY: BASKING RIDGE STATE: NJ ZIP: 07920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BeyondSpring Inc. CENTRAL INDEX KEY: 0001677940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR STREET 2: SUITE 410 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 646-528-4184 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR STREET 2: SUITE 410 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 3 1 ownership.xml 3 X0206 3 2024-12-31 0 0001677940 BeyondSpring Inc. BYSI 0001658859 Fabbio Patrick C/O BEYONDSPRING INC., 100 CAMPUS DRIVE WEST SIDE, 4TH FLOOR, SUITE 410 FLORHAM PARK NJ 07932 true false false false Ordinary Shares 24592 D Stock Options (right to buy) 11.03 2030-08-01 Ordinary Shares 5000 D Stock Options (right to buy) 12.2 2031-01-01 Ordinary Shares 10000 D Stock Options (right to buy) 4.53 2032-01-01 Ordinary Shares 10000 D Stock Options (right to buy) 1.99 2032-03-07 Ordinary Shares 10000 D Stock Options (right to buy) 2.68 2033-02-10 Ordinary Shares 15000 D Stock Options (right to buy) 0.9835 2033-05-08 Ordinary Shares 25000 D Stock Options (right to buy) 0.9 2034-01-01 Ordinary Shares 10000 D Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 5,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 10,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 15,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 25,000 stock options are fully vested and exercisable. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. None of the stock options have become fully vested and exercisable. 10,000 of the stock options will vest on January 1, 2025. As the Company no longer qualifies as a foreign private issuer, effective January 1, 2025, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company determined that it qualified as a foreign private issuer under the Exchange Act. /s/ Patrick Fabbio 2024-12-31